Danielle Keller
Physician Assistant · Union City, TNNPI 1366098436
Payments from drug & device makers
Across 121 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$748
- Boehringer Ingelheim$199
- Harmony Biosciences LLC$181
- Novo Nordisk$142
- Novartis$136
- United Therapeutics Corporation$133
- plus $804 from 13 others
What the payments were for
- Food & beverage$2,27997%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 38 | $748 |
| Boehringer Ingelheim | 8 | $199 |
| Harmony Biosciences LLC | 6 | $181 |
| Novo Nordisk | 6 | $142 |
| Novartis | 8 | $136 |
| United Therapeutics Corporation | 8 | $133 |
| AstraZeneca | 7 | $126 |
| Electromed, Inc. | 10 | $119 |
| Bayer | 5 | $113 |
| Aerin Medical Inc. | 5 | $111 |
| Mylan Specialty L.p. | 6 | $105 |
| AbbVie | 4 | $62 |
| Shield Therapeutics Inc | 3 | $52 |
| Baxter Healthcare | 2 | $36 |
| Stryker | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Merck | 1 | $14 |
| Optinose US, Inc. | 1 | $14 |
How this compares
$2,344 in reported general payments places this provider in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 245 | $239,790 |
| Humira(Cf) PenAdalimumab | 14 | $197,738 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 80 | $61,138 |
| TrulicityDulaglutide | 11 | $16,449 |
| EliquisApixaban | 19 | $15,201 |
| FarxigaDapagliflozin Propanediol | 13 | $13,694 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $12,148 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $11,315 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 19 | $10,094 |
| SymbicortBudesonide/Formoterol Fumarate | 25 | $6,937 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,206 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 148 | $3,658 |
| Azelastine Hcl | 23 | $1,159 |
| Montelukast Sodium | 76 | $987 |
| Atorvastatin Calcium | 49 | $844 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $748 | $263,253283 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $126 | $81,768118 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $199 | $16,29931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Union City
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.